Towards eliminating minimal residual disease in ovarian cancer to prevent recurrence

OxTalks is Changing

During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).

If you have any questions, please contact halo@digital.ox.ac.uk

Towards eliminating minimal residual disease in ovarian cancer to prevent recurrence

Abstract:
Over the last decade, our research provides strong evidence that the drivers of minimal residual disease (MRD) survival are different from those that drive bulk ovarian cancer. Therefore, eliminating minimal residual disease at the end of traditional treatment requires rationalised therapeutics that specifically target MRD drivers. In this talk I will discuss our recent work in characterising MRD in ovarian cancer and our ongoing work to develop therapeutics to eliminate it.

Date: 7 November 2023, 13:00
Venue: This event is hybrid
Speaker: Professor Ahmed Ahmed (University of Oxford )
Organising department: Nuffield Department of Women's and Reproductive Health
Organisers: Michael Suttie (NDWRH, University of Oxford), Dr Lydia Coxon (NDWRH, University of Oxford)
Organiser contact email address: seminars@wrh.ox.ac.uk
Booking required?: Recommended
Booking email: seminars@wrh.ox.ac.uk
Audience: Members of the University only
This talk features in the following public collections:
- Talks of Interest to Medical Sciences
- Talks of interest to the Nuffield Department of Women's & Reproductive Health
Editor: Isobel Way